On May 11, 2023, the Office of Technology Management hosted the sixth annual Celebration of Inventors, an event to honor and recognize Washington University inventors, researchers and faculty entrepreneurs. Honorees included 2022 United States Patent and Trademark Office (USPTO) awardees and the National Academy of Inventors fellows and senior member. This year’s event also recognized […]
Author: Leslie Roettger
Class Acts: Carolyn Duncan (Links to an external site)
Energized by St. Louis startup scene, Duncan will work for a bioscience firm with WashU roots
Findings may lead to improved insulin-secreting cells derived from stem cells (Links to an external site)
Researchers ID shortcomings in stem cell-derived beta cells, paving way to improved diabetes treatments
Washington University receives NSF Engines Development Award (Links to an external site)
Award will help advance neuroscience technologies aimed at improving cognitive wellness
Needleman innovation program seeks proposals for therapeutic development (Links to an external site)
Up to $4 million in funding available to pursue ‘investigational new drug’ status
Commission presents venture capital funding gap solutions (Links to an external site)
Recommendations include tracking progress, policy changes, increased public awareness
Yang elected senior member of National Academy of Inventors (Links to an external site)
Lan Yang, the Edwin H. & Florence G. Skinner Professor in the Preston M. Green Department of Electrical & Systems Engineering at the McKelvey School of Engineering at Washington University in St. Louis, has been elected a senior member of the National Academy of Inventors (NAI).
Scientists aim to develop vaccine against all deadly coronaviruses (Links to an external site)
Washington University School of Medicine in St. Louis scientists Michael S. Diamond, MD, PhD, and Sean Whelan, PhD, lead a team working to minimize the risk of another devastating coronavirus pandemic by designing a vaccine that reduces sickness and death caused by all potentially deadly coronaviruses, including ones that have not yet affected people. The research is supported by an $8 million grant from the National Institute for Allergy and Infectious Diseases of the National Institutes of Health (NIH).
Improving women’s health with engineering (Links to an external site)
Tools and techniques of engineering can be applied to diagnosis, treatment and prevention in women’s health
Imaging tech produces real-time 3D maps of uterine contractions during labor (Links to an external site)
Noninvasive technique could shed light on preterm birth
New diagnostic test is 1,000 times more sensitive than conventional tests (Links to an external site)
When Srikanth Singamaneni and Guy Genin, both professors of mechanical engineering and materials science at the McKelvey School of Engineering at Washington University in St. Louis, established a new collaboration with researchers from the School of Medicine in late 2019, they didn’t know the landscape of infectious disease research was about to shift dramatically. In a conference room […]
WashU Medicine reaches new heights as it climbs to No. 3 in NIH research funding (Links to an external site)
Research flourishes despite the immense challenges of the pandemic
Gordon receives Dr. Paul Janssen Award for Biomedical Research (Links to an external site)
‘Father of the field’ honored for gut microbiome research
O’Brien team wins NIH prize to further develop maternal health device (Links to an external site)
Christine O’Brien, an assistant professor of biomedical engineering at the McKelvey School of Engineering at Washington University in St. Louis, and her team have received a $20,000 prize from the National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics Technology for Maternal Health Challenge.
Genin, Guilak named to National Academy of Inventors (Links to an external site)
Faculty members honored for ‘facilitating outstanding inventions’
Nasal COVID-19 vaccine approved in India based on Washington University technology (Links to an external site)
The world’s first nasal vaccine for COVID-19 was approved Tuesday, Sept. 6, in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University in St. Louis and developed in collaboration with Bharat Biotech International Limited in India.